Literature DB >> 10674633

Diurnal variation in orexin A immunoreactivity and prepro-orexin mRNA in the rat central nervous system.

S Taheri1, D Sunter, C Dakin, S Moyes, L Seal, J Gardiner, M Rossi, M Ghatei, S Bloom.   

Abstract

Orexins are a family of neuropeptides originally believed to be important mediators of food intake. The wide distribution of orexins and their receptors, however, has suggested other regulatory functions for these peptides including involvement in sleep and arousal mechanisms. In this study, we have demonstrated diurnal variation in orexin A immunoreactivity in the pons, from where locus coeruleus noradrenergic neurones innervate other brain areas to stimulate arousal, and in the preoptic/anterior hypothalamic region, an area implicated in the regulation of sleep and circadian rhythms. Orexin A immunoreactivity decreased by 50% in the preoptic/anterior hypothalamus from 09:00 to 21:00 h (P < 0.0001), whilst in the pons, it increased by over 30% from 09:00 to 01:00 h (P = 0.02). Prepro-orexin mRNA also displayed diurnal variation. This further suggests that orexins are involved in the regulation of the sleep/wake cycle.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10674633     DOI: 10.1016/s0304-3940(99)00955-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  35 in total

1.  Release of hypocretin (orexin) during waking and sleep states.

Authors:  Lyudmila I Kiyashchenko; Boris Y Mileykovskiy; Nigel Maidment; Hoa A Lam; Ming-Fung Wu; Joshi John; John Peever; Jerome M Siegel
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

2.  [The neurotransmitter, hypocretin. An overview].

Authors:  C Baumann; C Bassetti
Journal:  Nervenarzt       Date:  2004-04       Impact factor: 1.214

3.  Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials.

Authors:  W Joseph Herring; Kathleen M Connor; Ellen Snyder; Duane B Snavely; Ying Zhang; Jill Hutzelmann; Deborah Matzura-Wolfe; Ruth M Benca; Andrew D Krystal; James K Walsh; Christopher Lines; Thomas Roth; David Michelson
Journal:  J Clin Sleep Med       Date:  2016-09-15       Impact factor: 4.062

4.  Antagonism of orexin 1 receptors eliminates motor hyperactivity and improves homing response acquisition in juvenile rats exposed to alcohol during early postnatal period.

Authors:  Georg M Stettner; Leszek Kubin; Denys V Volgin
Journal:  Behav Brain Res       Date:  2011-03-21       Impact factor: 3.332

5.  A possible role of neuropeptide Y, agouti-related protein and leptin receptor isoforms in hypothalamic programming by perinatal feeding in the rat.

Authors:  M López; L M Seoane; S Tovar; M C García; R Nogueiras; C Diéguez; R M Señarís
Journal:  Diabetologia       Date:  2004-12-23       Impact factor: 10.122

6.  Role of orexin input in the diurnal rhythm of locus coeruleus impulse activity.

Authors:  Heinrich S Gompf; Gary Aston-Jones
Journal:  Brain Res       Date:  2008-06-03       Impact factor: 3.252

Review 7.  Circadian rhythms and sleep--the metabolic connection.

Authors:  Urs Albrecht
Journal:  Pflugers Arch       Date:  2011-06-28       Impact factor: 3.657

8.  Promotion of Wakefulness and Energy Expenditure by Orexin-A in the Ventrolateral Preoptic Area.

Authors:  Vijayakumar Mavanji; Claudio E Perez-Leighton; Catherine M Kotz; Charles J Billington; Sairam Parthasarathy; Christopher M Sinton; Jennifer A Teske
Journal:  Sleep       Date:  2015-09-01       Impact factor: 5.849

9.  Transcriptional regulation of the hypocretin/orexin gene by NR6A1.

Authors:  Susumu Tanaka; Tohru Kodama; Takashi Nonaka; Hiromi Toyoda; Makoto Arai; Miyuki Fukazawa; Yoshiko Honda; Makoto Honda; Emmanuel Mignot
Journal:  Biochem Biophys Res Commun       Date:  2010-11-05       Impact factor: 3.575

10.  A major role for perifornical orexin neurons in the control of glucose metabolism in rats.

Authors:  Chun-Xia Yi; Mireille J Serlie; Mariette T Ackermans; Ewout Foppen; Ruud M Buijs; Hans P Sauerwein; Eric Fliers; Andries Kalsbeek
Journal:  Diabetes       Date:  2009-07-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.